Research Article
EI24 Suppresses Tumorigenesis in Pancreatic Cancer via Regulating c-Myc
Table 1
Associations of EI24 expression with clinicopathological characteristics in PDAC patients.
| Clinical parameters | Total (36) | EI24 expression | value | Low () | High () |
| Gender | | | | 0.2651 | Male | 21 | 15 | 6 | | Female | 15 | 8 | 7 | | Age (years) | | | | 0.6359 | ≤60 | 10 | 7 | 3 | | >60 | 26 | 16 | 10 | | Histological differentiation | | | | 0.9685 | Moderate/~well | 22 | 14 | 8 | | Poor/~moderate | 14 | 9 | 5 | | T classification | | | | 0.6436 | T1 + T2 | 7 | 5 | 2 | | T3 + T4 | 29 | 18 | 11 | | N classification | | | | 0.3187 | Absent | 21 | 12 | 9 | | Present | 15 | 11 | 4 | | Metastasis | | | | 0.6789 | No | 29 | 19 | 10 | | Yes | 7 | 4 | 3 | |
|
|